Muthusamy Shanmugam - Aug 14, 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Signature
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Aug 14, 2023
Transactions value $
-$3,067,450
Form type
4
Date filed
8/16/2023, 08:07 PM
Previous filing
Jul 21, 2023
Next filing
Aug 30, 2023

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.12 to $62.58, inclusive.
F3 The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.81 to $62.59, inclusive.
F5 The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.